ArticleDiagnostics (Basel, Switzerland)2023

Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study.

Felix Peisen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.